Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000347962

Medchemexpress LLC ALK4290 (AKST4290) | 1251528-23-0 | >99.8% | 512.04 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY136788100MG

Encompass_Preferred

ALK4290 (AKST4290) is a potent and orally active CCR3 inhibitor, derived from patent US20130261153A1, compound Example 2, demonstrating a Ki of 3.2 nM for human CCR3. This compound is suitable for research related to neovascular age-related macular degeneration and Parkinsonism.

  • Potent and orally active CCR3 inhibitor.
  • Exhibits a Ki of 3.2 nM for hCCR3.
  • Used in research for neovascular age-related macular degeneration.
  • Used in research for Parkinsonism.
  • Available in high purity (99.79%).
  • Offered in both solid and solution forms for research use.

Catalog No. 50-003-47962


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.